Analysis of genotypes associated with the treatment effects of Lucentis for age-related macular degeneratio
Not Applicable
- Conditions
- age-related macular degeneration
- Registration Number
- JPRN-UMIN000005584
- Lead Sponsor
- Kyoto University Graduate School of Medicine, Department of Ophthalmology and Visual Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
Previous treatment with photocoagulation, surgery, photodynamic therapy, Transpupillary thermotherapy, radiation Subfoveal fibrosis or atrophy History of vitrectomy Intraocular surgery within 2 months CNV in either eye due to other causes, such as ocular histo-plasmosis, trauma, or pathological myopia Aphakia or absence of the posterior capsule in the study eye unless it resulted from yttrium aluminum garnet (YAG) posterior capsulotomy in association with prior posterior chamber intraocular lens implantation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method visual acuity change at 12 months after the first treatment
- Secondary Outcome Measures
Name Time Method disappearance of retinal exudative change at 3 months, visual acuity change at 3 months, interval for additional treatment, and number of treatment during 12 months